144 related articles for article (PubMed ID: 30038510)
1. A cost-benefit analysis of smoking cessation prescription coverage from a US payer perspective.
Baker CL; Ding Y; Ferrufino CP; Kowal S; Tan J; Subedi P
Clinicoecon Outcomes Res; 2018; 10():359-370. PubMed ID: 30038510
[TBL] [Abstract][Full Text] [Related]
2. Estimated Budget Impact of Adopting the Affordable Care Act's Required Smoking Cessation Coverage on United States Healthcare Payers.
Baker CL; Ferrufino CP; Bruno M; Kowal S
Adv Ther; 2017 Jan; 34(1):156-170. PubMed ID: 27888437
[TBL] [Abstract][Full Text] [Related]
3. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
O'Donnell MP; Roizen MF
Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
[TBL] [Abstract][Full Text] [Related]
4. State Medicaid Expansion Tobacco Cessation Coverage and Number of Adult Smokers Enrolled in Expansion Coverage - United States, 2016.
DiGiulio A; Haddix M; Jump Z; Babb S; Schecter A; Williams KS; Asman K; Armour BS
MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(48):1364-1369. PubMed ID: 27932786
[TBL] [Abstract][Full Text] [Related]
5. The return on investment of a Medicaid tobacco cessation program in Massachusetts.
Richard P; West K; Ku L
PLoS One; 2012; 7(1):e29665. PubMed ID: 22238633
[TBL] [Abstract][Full Text] [Related]
6. Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers.
Lin DH; Jones CM; Compton WM; Heyward J; Losby JL; Murimi IB; Baldwin GT; Ballreich JM; Thomas DA; Bicket M; Porter L; Tierce JC; Alexander GC
JAMA Netw Open; 2018 Jun; 1(2):e180235. PubMed ID: 30646077
[TBL] [Abstract][Full Text] [Related]
7. Smoking Cessation Pharmacotherapy Utilization and Costs to a Medicaid Managed Care Plan.
Corelli RL; Tu TG; Lee KJ; Dinh D; Gericke KR; Hudmon KS
Pharmacoecon Open; 2021 Dec; 5(4):649-653. PubMed ID: 34109569
[TBL] [Abstract][Full Text] [Related]
8. Receipt of Cessation Treatments Among Medicaid Enrollees Trying to Quit Smoking.
Wang X; Babb S; Xu X; Ku L; Glover-Kudon R; Armour BS
Nicotine Tob Res; 2021 May; 23(6):1074-1078. PubMed ID: 33524992
[TBL] [Abstract][Full Text] [Related]
9. National Trends in Cessation Counseling, Prescription Medication Use, and Associated Costs Among US Adult Cigarette Smokers.
Tibuakuu M; Okunrintemi V; Jirru E; Echouffo Tcheugui JB; Orimoloye OA; Mehta PK; DeFilippis AP; Blaha MJ; Michos ED
JAMA Netw Open; 2019 May; 2(5):e194585. PubMed ID: 31125108
[TBL] [Abstract][Full Text] [Related]
10. Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015.
Yue X; Guo JJ; Wigle PR
Am Health Drug Benefits; 2018 Sep; 11(6):275-285. PubMed ID: 30464795
[TBL] [Abstract][Full Text] [Related]
11. Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis.
Sung HY; Penko J; Cummins SE; Max W; Zhu SH; Bibbins-Domingo K; Kohatsu ND
Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S148-S158. PubMed ID: 30454669
[TBL] [Abstract][Full Text] [Related]
12. Prescription drugs: issues of cost, coverage, and quality.
Copeland C
EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
[TBL] [Abstract][Full Text] [Related]
13. Affordable Care Act Impact on Medicaid Coverage of Smoking-Cessation Treatments.
McMenamin SB; Yoeun SW; Halpin HA
Am J Prev Med; 2018 Apr; 54(4):479-485. PubMed ID: 29433953
[TBL] [Abstract][Full Text] [Related]
14. Impact of U.S. federal and state generic drug policies on drug use, spending, and patient outcomes: A systematic review.
Mishuk AU; Fasina I; Qian J
Res Social Adm Pharm; 2020 Jun; 16(6):736-745. PubMed ID: 31445986
[TBL] [Abstract][Full Text] [Related]
15. A Critical Analysis of Obamacare: Affordable Care or Insurance for Many and Coverage for Few?
Manchikanti L; Helm Ii S; Benyamin RM; Hirsch JA
Pain Physician; 2017 Mar; 20(3):111-138. PubMed ID: 28339427
[TBL] [Abstract][Full Text] [Related]
16. Gaining Coverage Through Medicaid Or Private Insurance Increased Prescription Use And Lowered Out-Of-Pocket Spending.
Mulcahy AW; Eibner C; Finegold K
Health Aff (Millwood); 2016 Sep; 35(9):1725-33. PubMed ID: 27534776
[TBL] [Abstract][Full Text] [Related]
17. Utilization of smoking cessation medication benefits among medicaid fee-for-service enrollees 1999-2008.
Kahende J; Malarcher A; England L; Zhang L; Mowery P; Xu X; Sevilimedu V; Rolle I
PLoS One; 2017; 12(2):e0170381. PubMed ID: 28207744
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
[TBL] [Abstract][Full Text] [Related]
19. Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic framework.
Connolly MP; Baker CL; Kotsopoulos N
J Med Econ; 2018 Jun; 21(6):571-576. PubMed ID: 29376747
[TBL] [Abstract][Full Text] [Related]
20. The impact of tobacco dependence treatment coverage and copayments in Medicaid.
Greene J; Sacks RM; McMenamin SB
Am J Prev Med; 2014 Apr; 46(4):331-6. PubMed ID: 24650835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
